FNDC8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.85162996046984E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63202784619898E-12 |
Normal-vs-Stage2 |
2.245900E-02 |
Normal-vs-Stage3 |
1.56744999999514E-05 |
Normal-vs-Stage4 |
2.95110000003707E-06 |
Stage1-vs-Stage2 |
4.441000E-03 |
Stage1-vs-Stage3 |
3.735500E-02 |
Stage1-vs-Stage4 |
1.516570E-01 |
Stage2-vs-Stage3 |
2.273200E-01 |
Stage2-vs-Stage4 |
1.185640E-01 |
Stage3-vs-Stage4 |
6.990800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.99749114418546E-12 |
Normal-vs-AfricanAmerican |
1.54316999999571E-05 |
Normal-vs-Asian |
3.183200E-01 |
Caucasian-vs-AfricanAmerican |
1.525560E-01 |
Caucasian-vs-Asian |
6.988800E-01 |
AfricanAmerican-vs-Asian |
4.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.33859590079055E-11 |
Normal-vs-Female |
1.37370004260617E-10 |
Male-vs-Female |
5.733000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.999600E-03 |
Normal-vs-Age(41-60Yrs) |
2.80160006305152E-10 |
Normal-vs-Age(61-80Yrs) |
6.3984373355197E-12 |
Normal-vs-Age(81-100Yrs) |
5.445600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.665200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.061200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.566000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.146600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.091400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.792200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.153900E-04 |
Normal-vs-Grade 2 |
2.72926126143602E-12 |
Normal-vs-Grade 3 |
1.7280999964342E-08 |
Normal-vs-Grade 4 |
4.4496000000005E-05 |
Grade 1-vs-Grade 2 |
7.881100E-03 |
Grade 1-vs-Grade 3 |
1.295720E-03 |
Grade 1-vs-Grade 4 |
1.016260E-02 |
Grade 2-vs-Grade 3 |
1.252840E-01 |
Grade 2-vs-Grade 4 |
5.161700E-02 |
Grade 3-vs-Grade 4 |
5.271000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63813407283442E-12 |
Normal-vs-ccB subtype |
2.641000E-04 |
ccA subtype-vs-ccB subtype |
1.624960E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.37660000065765E-08 |
Normal-vs-N1 |
1.988020E-02 |
N0-vs-N1 |
2.835800E-01 |
|
|